Shutterstock
This is the third and last in a series of interviews with a collection of subject matter experts (SMEs) operating throughout Lonza. We have, over the last six months, covered a range of topics that the company covers, and heard from some of the foremost experts in the world of pharma - this final collection of questions and answers is no different.